Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP26A1 | O43174 | 7/20 | 0.56 |
| ▸ | PPARG | P37231 | 3/20 | 0.52 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.48 |
| ▸ | CYP24A1 | Q07973 | 1/20 | 0.48 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.45 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | MAOB | P27338 | 1/20 | 0.45 |
| ▸ | PPARA | Q07869 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10689114 | 0.90 | PPARG (0.53) | CYP26A1PPARGFFAR1CYP19A1MAPT | |
| SCHEMBL10688836 | 0.83 | ALDH1A1 (0.51) | CYP26A1PPARGFFAR1MAPTALDH1A1 | |
| SCHEMBL10686431 | 0.80 | PPARG (0.52) | CYP26A1PPARGFFAR1CYP19A1MAPT | |
| SCHEMBL10690190 | 0.80 | PPARG (0.52) | PPARGFFAR1CYP19A1MAPTALDH1A1 | |
| SCHEMBL10685328 | 0.80 | CYP26A1 (0.50) | CYP26A1CYP24A1CYP19A1DDB1CRBN | |
| Englitazone SCHEMBL20125577 | 0.78 | PPARG (0.50) | PPARGFFAR1MAPTALDH1A1NPSR1 | |
| Englitazone SCHEMBL37697 | 0.78 | PPARG (0.50) | PPARGFFAR1MAPTALDH1A1NPSR1 | |
| Englitazone SCHEMBL4727851 | 0.78 | PPARG (0.50) | PPARGFFAR1MAPTALDH1A1NPSR1 | |
| Englitazone SCHEMBL20125579 | 0.78 | PPARG (0.50) | PPARGFFAR1MAPTALDH1A1NPSR1 | |
| Englitazone SCHEMBL29377687 | 0.78 | PPARG (0.50) | PPARGFFAR1MAPTALDH1A1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4738972-A | Hypoglycemic thiazolidinediones | PFIZER INC. (US) | 1988-04-19 | — | — | US | disclosed |